Timolol-Brimonidine-Dorzolamide-Latanoprost recall: Labeling Error
Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or…
Why was Timolol-Brimonidine-Dorzolamide-Latanoprost recalled?
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
05092017@2B, 11/5/2017
- Product
- Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or…
- Recalling firm
- ImprimisRx CA, Inc., dba ImprimisRx
- Quantity
- 2 bottles
- Distribution
- Nationwide
- Recall date
- September 13, 2017
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)